ArticleFrontiers in molecular biosciences2022

Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer.

Alexander Gudkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.